Adjuvant Therapy for Renal Cell Carcinoma After Metastatectomy: A Focus on Therapy Intensification.

IF 4.8 2区医学 Q1 UROLOGY & NEPHROLOGY

European urology focus Pub Date : 2025-05-23 DOI:10.1016/j.euf.2025.05.005

Michael Serzan

引用次数: 0

Abstract

Adjuvant therapy for patients with completely resected metastases in renal cell carcinoma remains a clinical conundrum. Owing to the high risk of disease recurrence, several clinical trials are investigating treatment intensification with combination regimens aimed at improving efficacy and limiting toxicity.

查看原文本刊更多论文

肾细胞癌转移切除术后的辅助治疗：强化治疗的焦点。

肾细胞癌完全切除转移患者的辅助治疗仍然是一个临床难题。由于疾病复发的高风险，一些临床试验正在研究联合治疗方案的强化治疗，旨在提高疗效和限制毒性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology focus Medicine-Urology

CiteScore

10.40

自引率

3.70%

发文量

274

审稿时长

23 days

期刊介绍： European Urology Focus is a new sister journal to European Urology and an official publication of the European Association of Urology (EAU). EU Focus will publish original articles, opinion piece editorials and topical reviews on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcome basic and translational research articles in the field of urological diseases. Authors may be solicited by the Editor directly. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.